Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 20...( IRVINE Calif. Jan. 12 /- Alsius C...),Health

IRVINE, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced preliminary, unaudited record fourth quarter and year ended December 31, 2008 revenue.

Fourth quarter 2008 revenue improved more than 40 percent to an expected quarterly record of approximately $3.8 million, compared with $2.7 million in the fourth quarter of 2007. Full year 2008 revenue is expected to be approximately $12.4 million, an annual record, compared with $9.1 million for the full year of 2007. Complete fourth quarter and year-end results will be finalized and reported in early March after completion of the annual audit.

In addition to strong revenue, the number of systems and catheters Alsius sold in the United States during the fourth quarter of 2008 also marked a new high. Sales in Europe increased solidly from the previous year, as well.

"The achievement of record revenue in each of the last three quarters, especially in today's tough capital spending environment, is a testament to two factors: quality products addressing a significant need and adept execution," said Bill Worthen, president and CEO of Alsius. "Expanding awareness among healthcare providers of our IVTM solutions is serving to increase U.S. demand. We are seeing temperature management increasingly incorporated into treatment protocols, as is evidenced by New York City's recent requirement that therapeutic cooling must be available to cardiac arrest victims transported in city ambulances. This growing recognition coupled with the hard work of the Alsius team served to deliver record results. In addition, we were able to build our pipeline of leads during the quarter, which further confirms our belief in the opport
'/>"/>